← Open Payments lookup

TIFFANY SHAUGHNESSY: Open Payments

NPI 1952980518 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$749 in 33 payments from 9 companies in 2025. Trend: 2023 $413 · 2024 $719 · 2025 $749

Food & beverage: $749
CompanyPaymentsAmount
ABBVIE INC.12$256
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$184
Otsuka America Pharmaceutical, Inc.5$114
E.R. Squibb & Sons, L.L.C.5$84
Alkermes, Inc.2$47
Neurocrine BioSciences, Inc.1$27
Teva Pharmaceuticals USA, Inc.1$15
Luye Pharma (USA) Ltd.1$15
Corium, LLC1$8

Products named: VRAYLAR, CAPLYTA, COBENFY, ABILIFY ASIMTUFII, ABILIFY MAINTENA, LYBALVI, INGREZZA, ARISTADA.

Industry payments across NY — which companies pay providers there.